Authors

• Hannah Gilligan
• Jamil Azzi (ORCID: https://orcid.org/0000-0002-6909-4645)
• Nitender Goyal (ORCID: https://orcid.org/0000-0001-9539-9111)
• Marc Raynaud (ORCID: https://orcid.org/0000-0003-0275-7501)
• Orhan Efe (ORCID: https://orcid.org/0000-0003-4852-9061)
• Alexandre Loupy (ORCID: https://orcid.org/0000-0003-3388-7747)
• Astrid Weins (ORCID: https://orcid.org/0000-0002-1633-0245)
• Kassem Safa (ORCID: https://orcid.org/0000-0001-6447-3227)
• Ayman Al Jurdi (ORCID: https://orcid.org/0000-0002-7652-3399)
• Leonardo V. Riella (ORCID: https://orcid.org/0000-0002-7636-3196)
• David Wojciechowski
• Mariesa Cote
• Morgan Mabey Eiting
• Christine Rogers Marks

Institutions

• Brigham and Women's Hospital (US)
• Tufts Medical Center (US)
• Harvard University (US)
• Inserm (FR)
• Université Paris Cité (FR)
• Massachusetts General Hospital (US)
• Paris Cardiovascular Research Center (FR)
• Southwestern Medical Center (US)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

Frontiers in Immunology

Published

2024-12-23

DOI

https://doi.org/10.3389/fimmu.2024.1491514

Primary Topic

Renal Transplantation Outcomes and Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Bristol-Myers Squibb